Clinical Trials at Novartis Italy
During the past decade, Novartis Italy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Novartis Italy
According to Clinical.Site data, the most researched conditions in "Novartis Italy" are
"Amyotrophic Lateral Sclerosis" (1 trials) and "Staphylococcal Skin Infections" (1 trials). Many other conditions were trialed in "Novartis Italy" in a lesser frequency.
Clinical Trials Intervention Types at Novartis Italy
Most popular intervention types in "Novartis Italy" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Daptomycin" (1 trials) and "TCH346" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Novartis Italy
The vast majority of trials in "Novartis Italy" are
2 trials for "All" genders.
Clinical Trials Status at Novartis Italy
Currently, there are NaN active trials in "Novartis Italy".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Novartis Italy,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Novartis Italy, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".